Skip to content
NK - 1 Antagonist Drug Interactions episode artwork

Feb 6, 2020 17 min

NK - 1 Antagonist Drug Interactions

from OncoPharm Hosted by John Bossaer

Drug-drug interactions are a key consideration when determining which NK-1 antagonist to use in patients receiving highly emetogenic chemotherapy. We discuss the issues for (fos)aprepitant, netupitant, & rolapitant. A nice aprepitant review (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595939/) and the case for an aprepitant-vincristine interaction (https://doi.org/10.1177/1078155219870840).

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

NK - 1 Antagonist Drug Interactions

0:00 17:04

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OncoPharm?

This episode is 17 minutes long.

When was this OncoPharm episode published?

This episode was published on February 6, 2020.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.